a significant trendp = 0.056
In the VHR group, the survival advantage of WPRT may be partly due to the younger age of the patients rather than the treatment modality itself (e.g., a significant trend in OS with p = 0.056).
In the VHR group, the survival advantage of WPRT may be partly due to the younger age of the patients rather than the treatment modality itself (e.g., a significant trend in OS with p = 0.056).